These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir. Gianotti N; Guffanti M; Galli L; Margonato A; Chiaravalli G; Bigoloni A; Lazzarin A; Castagna A AIDS; 2007 Jul; 21(12):1648-51. PubMed ID: 17630564 [TBL] [Abstract][Full Text] [Related]
7. FDA notifications. Updates made to Reyataz package insert. AIDS Alert; 2008 Oct; 23(10):116-7. PubMed ID: 18935687 [No Abstract] [Full Text] [Related]
8. Skin rash associated with atazanavir: report of three cases. Ouagari Z; Tubiana R; Mohand HA; Dominguez S; Duvivier C; Bricaire F; Katlama C; Caumes E AIDS; 2006 May; 20(8):1207-8. PubMed ID: 16691076 [No Abstract] [Full Text] [Related]
9. Rash in an HIV-positive patient. Herzmann C; Kinloch S; Johnson M HIV Med; 2005 Nov; 6(6):379. PubMed ID: 16268818 [No Abstract] [Full Text] [Related]
14. Atazanavir-containing renal calculi in an HIV-infected patient. Anderson PL; Lichtenstein KA; Gerig NE; Kiser JJ; Bushman LR AIDS; 2007 May; 21(8):1060-2. PubMed ID: 17457108 [No Abstract] [Full Text] [Related]
15. Atazanavir urinary stones in an HIV-infected patient. Pacanowski J; Poirier JM; Petit I; Meynard JL; Girard PM AIDS; 2006 Oct; 20(16):2131. PubMed ID: 17053366 [No Abstract] [Full Text] [Related]
16. Drug interactions. Kaletra and atazanavir. TreatmentUpdate; 2006; 18(3):7-8. PubMed ID: 17211919 [No Abstract] [Full Text] [Related]
17. A comparison of different protease inhibitors on coronary heart disease risk. Coleman CI; White CM Conn Med; 2007 Jan; 71(1):15-7. PubMed ID: 17288101 [No Abstract] [Full Text] [Related]
18. [New data on atazanavir/r]]. MMW Fortschr Med; 2005 Apr; 147 Spec No 1():81-3. PubMed ID: 16385887 [No Abstract] [Full Text] [Related]